Building on more than 10 years of research and collaboration on Mycoplasma hyopneumoniae (M. hyopneumoniae) control, Boehringer Ingelheim and the University of Minnesota have launched the M. hyopneumoniae Eradication Roadmap to equip veterinarians and producers with a holistic resource to inform, prepare and guide them through the M. hyopneumoniae eradication process.

The roadmap incorporates breakthrough research and guidance from the University of Minnesota College of Veterinary Medicine and Boehringer Ingelheim pertaining to refined exposure methods, diagnostic questions, day-0 determination and end-of-herd-closure confirmations, among others.

“The University of Minnesota has been a driving force behind M. hyopneumoniae eradication research for more than 10 years,” said Maria Pieters, DVM, PhD, Associate Professor with the Department of Veterinary Population Medicine, University of Minnesota College of Veterinary Medicine, and Director of the Swine Disease Eradication Center. “Boehringer Ingelheim has been a trusted research partner throughout that time, and we are proud to be launching this in collaboration with them, to provide the industry with this much-needed resource.” 

The M. hyopneumoniae Eradication Roadmap not only provides direction around the main elements and steps of an eradication program, but also outlines clear expectations of up-front costs and considerations to achieve it. Featuring key learnings, research and practical instruction from more than 25 industry thought leaders, including practicing veterinarians, producers and academics, the roadmap is a free and convenient, all-in-one resource.

“This Roadmap is unique in that it was born out of true industry collaboration,” said Amanda Sponheim, DVM, Key Account Veterinarian, Boehringer Ingelheim. “Until now, veterinarians would have had to piece together information and best practices from multiple sources to build a Mycoplasma hyopneumoniae eradication program. Thanks to the input of dozens of esteemed colleagues, the Roadmap is a one-stop-shop for planning and executing an eradication program.”

Free to access and designed to be used independently by producers and veterinarians, the M. hyopneumoniae Eradication Roadmap can be utilized with as much or as little support as is needed. Access the Roadmap here, or talk to your Boehringer Ingelheim veterinarian to learn more.

***

About Boehringer Ingelheim

Boehringer Ingelheim provides innovation for preventing and treating diseases in animals. The company offers a wide range of vaccines, parasite-control products, and medicines for pets, horses, and livestock to veterinarians, animal owners, farmers, and governments. As a leader in animal health, Boehringer Ingelheim values that the health of humans and animals is deeply connected and strives to make a difference for people, animals, and society.

Learn more at www.bi-animalhealth.com

About the University of Minnesota College of Veterinary Medicine 

The University of Minnesota College of Veterinary Medicine affects the lives of animals and people every day through educational, research, service and outreach programs.

Established in 1947, the University of Minnesota College of Veterinary Medicine is Minnesota’s only veterinary college. Fully accredited, the college has graduated over 4,000 veterinarians and hundreds of scientists. The college is also home to the Veterinary Medical Center, the Veterinary Diagnostic Laboratory, the Leatherdale Equine Center and The Raptor Center. Learn more at vetmed.umn.edu.

Media Contacts 

Lauren Housh  

Public Relations Supervisor, broadhead  

(302) 632-3661  

lhoush@broadheadco.com  

Beth Breeding   

Corporate Communications, Boehringer Ingelheim Animal Health  

(703) 946-0370  

elizabeth.breeding@boehringer-ingelheim.com

©2024 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All Rights Reserved. US-POR-0158-2023-A-V2